Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.

Saved in:
Bibliographic Details
Title: Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study'.
Authors: Stephan C; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Albuquerque B; Gilead Sciences GmbH, Martinsried, Germany., Schreiber S; Gilead Sciences GmbH, Martinsried, Germany.
Source: HIV medicine [HIV Med] 2026 Feb; Vol. 27 (2), pp. 324-325. Date of Electronic Publication: 2025 Dec 01.
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1468-1293
DOI:10.1111/hiv.70159